Somatostatin Analogues for Neuroendocrine Cancer: Lanreotide and Octreotide

Disclaimer: Educational and advocacy content only. Not a substitute for medical advice. Updated and reviewed 15th January 2025. Somatostatin Analogues are the ‘workhorse’ treatments for those living with NETs, particularly where certain syndromes are involved.  So not just for classic NETs with Carcinoid Syndrome but also for treating the hormone over secretions caused by insulinoma, gastrinoma, … Continue reading Somatostatin Analogues for Neuroendocrine Cancer: Lanreotide and Octreotide